These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The isolation and characterization of the promoter of the human type 1 inositol 1,4,5-trisphosphate receptor. Deelman LE; Jonk LJ; Henning RH Gene; 1998 Jan; 207(2):219-25. PubMed ID: 9511764 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of type 2 and type 3 inositol 1,4,5-trisphosphate receptor mRNAs in various mouse tissues: in situ hybridization study. Fujino I; Yamada N; Miyawaki A; Hasegawa M; Furuichi T; Mikoshiba K Cell Tissue Res; 1995 May; 280(2):201-10. PubMed ID: 7781020 [TBL] [Abstract][Full Text] [Related]
11. Functional expression of the type 1 inositol 1,4,5-trisphosphate receptor promoter-lacZ fusion genes in transgenic mice. Furutama D; Shimoda K; Yoshikawa S; Miyawaki A; Furuichi T; Mikoshiba K J Neurochem; 1996 May; 66(5):1793-801. PubMed ID: 8780003 [TBL] [Abstract][Full Text] [Related]
12. Promoter activity and regulation of the CYP4F2 leukotriene B(4) omega-hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells. Zhang X; Chen L; Hardwick JP Arch Biochem Biophys; 2000 Jun; 378(2):364-76. PubMed ID: 10860554 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1. Zhou D; Masri S; Ye JJ; Chen S Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749 [TBL] [Abstract][Full Text] [Related]
14. Molecular cloning, genomic organization, promoter activity, and tissue-specific expression of the mouse ryudocan gene. Tsuzuki S; Kojima T; Katsumi A; Yamazaki T; Sugiura I; Saito H J Biochem; 1997 Jul; 122(1):17-24. PubMed ID: 9276666 [TBL] [Abstract][Full Text] [Related]
15. Dissection of the promoter region of the inositol 1,4,5-trisphosphate receptor gene, itr-1, in C. elegans: a molecular basis for cell-specific expression of IP3R isoforms. Gower NJ; Temple GR; Schein JE; Marra M; Walker DS; Baylis HA J Mol Biol; 2001 Feb; 306(2):145-57. PubMed ID: 11237590 [TBL] [Abstract][Full Text] [Related]
16. Expression of inositol trisphosphate receptors. Taylor CW; Genazzani AA; Morris SA Cell Calcium; 1999 Dec; 26(6):237-51. PubMed ID: 10668562 [No Abstract] [Full Text] [Related]
17. Bcl-X(L) affects Ca(2+) homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors. Li C; Fox CJ; Master SR; Bindokas VP; Chodosh LA; Thompson CB Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9830-5. PubMed ID: 12118121 [TBL] [Abstract][Full Text] [Related]
18. Single channel function of recombinant type-1 inositol 1,4,5-trisphosphate receptor ligand binding domain splice variants. Ramos-Franco J; Caenepeel S; Fill M; Mignery G Biophys J; 1998 Dec; 75(6):2783-93. PubMed ID: 9826600 [TBL] [Abstract][Full Text] [Related]
19. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Matsumoto M; Nakagawa T; Inoue T; Nagata E; Tanaka K; Takano H; Minowa O; Kuno J; Sakakibara S; Yamada M; Yoneshima H; Miyawaki A; Fukuuchi Y; Furuichi T; Okano H; Mikoshiba K; Noda T Nature; 1996 Jan; 379(6561):168-71. PubMed ID: 8538767 [TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice. Li X; Zima AV; Sheikh F; Blatter LA; Chen J Circ Res; 2005 Jun; 96(12):1274-81. PubMed ID: 15933266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]